Open Access
Review
Table 2
Baseline patient characteristics.
| Variables | Case group (n = 40) | Control group (n = 80) | p-value |
|---|---|---|---|
| Age (years) | 70.5 ± 18.3 | 74.0 ± 18.1 | 0.12 |
| Gender (men), n (%) | 22 (55.0) | 44 (55.0) | 1 |
| Body mass index (kg m−2) | 27.9 ± 6.1 | 26.5 ± 5.7 | 0.14 |
| ASA score (1/2/3/4), n | 5/18/15/2 | 10/39/30/1 | 0.66 |
| Clinical Frailty Scale score | 2 [1–5] | 3 [1–5] | 0.425 |
| Smoking history, n (%) | 7 (17.5) | 9 (11.3) | 0.34 |
| Alcohol history n (%) | 6 (15.0) | 8 (10.0) | 0.42 |
| Neoplasia history n (%) | 1 (2.5) | 12 (15.0) | 0.06 |
| Diabetes mellitus history n (%) | 13 (32.5) | 12 (15.0) | 0.03 |
| Autoinflammation disease n (%) | 11 (27.5) | 3 (3.8) | < 0.001 |
| Anticoagulant use, n (%) | 8 (20.0) | 15 (18.8) | 0.87 |
| Anti-Platelet therapy use, n (%) | 8 (20.0) | 25 (31.3) | 0.19 |
| Immunosuppressive agent use, n (%) | 3 (7.5) | 1 (1.3) | 0.11 |
| Residential facilities, n (%) | 3 (7.5) | 8 (10.0) | 0.75 |
| Follow-up (months) | 73 ± 69 | 94 ± 31 | 0.56 |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.